Cardiac ischemia may lead to episodes of angina or chest pain. The slow build-up of plaque on the walls of the heart narrows the blood vessels and finally blocks them. Rapid flow of lipids through the vessels may also create a tear on the walls of the vessels causing aggregation of platelets and the formation of a clot. The clot formation causes obstruction of blood supply through the vessels, leading to necrosis or the death of tissues in the heart muscle.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Single User License: US$ 2500
No of Pages: 75 Corporate User License: US$ 4000
The analysts forecast global myocardial infarction drugs market to grow at a CAGR of 0.41% during the period
Myocardial infarction, commonly known as heart attack, is the irreparable death of the heart tissue. It occurs
when blood stops flowing to a part of the myocardium (heart muscle), depriving it of oxygen and nutrients. If
the coronary artery that supplies blood to the heart muscle is blocked by the formation of plaque (a substance
made of fat, cholesterol, and cellular waste), the heart is starved of oxygen, a condition called cardiac
ischemia, causing tissue damage. Cardiac ischemia may lead to episodes of angina or chest pain. The slow
build-up of plaque on the walls of the heart narrows the blood vessels and finally blocks them. Rapid flow of
lipids through the vessels may also create a tear on the walls of the vessels causing aggregation of platelets
and the formation of a clot. The clot formation causes obstruction of blood supply through the vessels, leading
to necrosis or the death of tissues in the heart muscle.
ViewComplete Report @ http://www.rnrmarketresearch.com/global-myocardial-infarction-drugs-market-2016-
This report covers the present scenario and the growth prospects of the global myocardial infarction drugs market
for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded,
generic, and off-label drugs used for the treatment and prevention of myocardial infarction.
The market is divided into the following segments based on geography: Americas, APAC and EMEA
The report, Global Myocardial Infarction Drugs Market 2016-2020, has been prepared based on an in-depth
market analysis with inputs from industry experts. This report covers the market landscape and its growth
prospects over the coming years. The report also includes a discussion of the key vendors operating in this
Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=508676
Key vendors –AstraZeneca, Bayer HealthCare, Eli Lilly, Novartis, Pfizer, Sanofi
Other prominent vendors –advanceCOR, Armaron Bio, Athersys, BioVascular, BMS, Caladrius, Capricor, CSL
Behring, GNT Pharma, GSK, Ischemix, Mesoblast, NeuroVive, Osiris Therapeutics, PledPharma, RegeneRx, Teva
Pharmaceuticals, TiGenix, US Stem Cell, Ventrix
Market driver - Growing older population
Market challenge - Alternative therapies
Market trend - Growing awareness of disease
Inquire on the Report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=508676
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=508676
RNRMARKETRESEARCH.COM, An online repository of market research reports, offers in-depth analysis of over 5000
market segments. RNR market research library has syndicated reports by leading market research publishers across
For more details contact : [email protected] / +18883915441